Contact
searchSearch
HMP Global
Login

Tardive Dyskinesia Topic Center

a medical professional communicates with a patient
Conference Coverage
Patient-Centered Communication Strategies May Improve Tardive Dyskinesia Treatment Uptake
03/22/2026
Maria Mantas
Recent research highlights how targeted communication strategies may improve treatment acceptance in patients with mental illness or tardive dyskinesia (TD).
Recent research highlights how targeted communication strategies may improve treatment acceptance in patients with mental illness or tardive dyskinesia (TD).
Recent research highlights how...
03/22/2026
Psych Congress Network
doctor holds hand of older patient
News
Valbenazine Effective for Long-Term Treatment of TD in Older Adults, Analysis Finds
05/21/2025
Maria Mantas
A post hoc analysis found that valbenazine was safe and effective for the long-term treatment of tardive dyskinesia (TD) in adults aged 65 and older.
A post hoc analysis found that valbenazine was safe and effective for the long-term treatment of tardive dyskinesia (TD) in adults aged 65 and older.
A post hoc analysis found that...
05/21/2025
Psych Congress Network
poster presentation session at a conference
Conference Coverage
Deutetrabenazine Targets VMAT2 With Precision, Analysis Finds
05/12/2025
Jolynn Tumolo
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
Deutetrabenazine showed...
05/12/2025
Psychiatry & Behavioral Health
From Psychiatry & Behavioral Health
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Jolynn Tumolo
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
: FDA Approves Oral Valbenazine Granule Formulation, an Alternative Administration Option for Adults With TD
News
FDA Approves Oral Valbenazine Granule Formulation, an Alternative Administration Option for Adults With TD
05/15/2024
Evi Arthur
At the end of April, Neurocrine Biosciences, Inc. announced the approval of INGREZZA® SPRINKLE (valbenazine) capsules by the FDA. This approval provides an alternative option for patients with dysphagia or who have difficulty swallowing. 
At the end of April, Neurocrine Biosciences, Inc. announced the approval of INGREZZA® SPRINKLE (valbenazine) capsules by the FDA. This approval provides an alternative option for patients with dysphagia or who have difficulty swallowing. 
At the end of April, Neurocrine...
05/15/2024
Psych Congress Network
TD Has ‘Severe Impact’ on Patients and Caregivers
News
TD Has ‘Severe Impact’ on Patients and Caregivers
05/10/2024
Evi Arthur
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was...
05/10/2024
Psych Congress Network
Geriatric Patient with son in long term care setting
News
High Comorbidity, Polypharmacy Burden in Patients With Tardive Dyskinesia in LTC Settings
05/07/2024
Jolynn Tumolo
Patients with tardive dyskinesia (TD) in long-term care settings have a high comorbidity and polypharmacy burden, with half taking medications that may worsen TD, according to a poster presentation at the APA annual meeting.
Patients with tardive dyskinesia (TD) in long-term care settings have a high comorbidity and polypharmacy burden, with half taking medications that may worsen TD, according to a poster presentation at the APA annual meeting.
Patients with tardive dyskinesia...
05/07/2024
Psych Congress Network
Amber Hoberg, MSN, APRN, PMHNP-BC
Videos
Clinical Pearls to Enhance Tardive Dyskinesia Treatment
01/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
n this video, Tardive Dyskinesia Section Editor Amber Hoberg, MSN, APRN, PMHNP-BC, of Med Management Associates, offers clinical pearls that clinicians can implement to optimize their tardive dyskinesia care.
n this video, Tardive Dyskinesia Section Editor Amber Hoberg, MSN, APRN, PMHNP-BC, of Med Management Associates, offers clinical pearls that clinicians can implement to optimize their tardive dyskinesia care.
n this video, Tardive Dyskinesia...
01/10/2024
Psych Congress Network
amber hoberg, np
Expert Insights Quiz
What screeners should be used to diagnose tardive dyskinesia?
05/26/2023
True or False: According to Nurse Amber Hoberg, the AIMS is the only scale that should be used when screening a patient for tardive dyskinesia (TD).
True or False: According to Nurse Amber Hoberg, the AIMS is the only scale that should be used when screening a patient for tardive dyskinesia (TD).
True or False: According to...
05/26/2023
Psych Congress Network
Elderly patient and his doctor
News
Awareness of TD Symptoms Linked With Poorer Health, Social Functioning in Patients
05/15/2023
Jolynn Tumolo
Clinician-confirmed possible tardive dyskinesia (TD) was associated with diminished wellness and social functioning in real-world patients, according to a study published online in the Journal of Patient-Reported Outcomes.
Clinician-confirmed possible tardive dyskinesia (TD) was associated with diminished wellness and social functioning in real-world patients, according to a study published online in the Journal of Patient-Reported Outcomes.
Clinician-confirmed possible...
05/15/2023
Psych Congress Network
quiz
Expert Insights Quiz
How does tardive dyskinesia impact medication adherence?
02/14/2023
True or false: Patients with Tardive Dyskinesia (TD) have high rates of antipsychotic medication non-adherence partly due to their TD symptoms.
True or false: Patients with Tardive Dyskinesia (TD) have high rates of antipsychotic medication non-adherence partly due to their TD symptoms.
True or false: Patients with...
02/14/2023
Psych Congress Network

News

doctor holds hand of older patient
News
Valbenazine Effective for Long-Term Treatment of TD in Older Adults, Analysis Finds
05/21/2025
Maria Mantas
A post hoc analysis found that valbenazine was safe and effective for the long-term treatment of tardive dyskinesia (TD) in adults aged 65 and older.
A post hoc analysis found that valbenazine was safe and effective for the long-term treatment of tardive dyskinesia (TD) in adults aged 65 and older.
A post hoc analysis found that...
05/21/2025
Psych Congress Network
poster presentation session at a conference
Conference Coverage
Deutetrabenazine Targets VMAT2 With Precision, Analysis Finds
05/12/2025
Jolynn Tumolo
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
Deutetrabenazine showed...
05/12/2025
Psychiatry & Behavioral Health
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Jolynn Tumolo
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
: FDA Approves Oral Valbenazine Granule Formulation, an Alternative Administration Option for Adults With TD
News
FDA Approves Oral Valbenazine Granule Formulation, an Alternative Administration Option for Adults With TD
05/15/2024
Evi Arthur
At the end of April, Neurocrine Biosciences, Inc. announced the approval of INGREZZA® SPRINKLE (valbenazine) capsules by the FDA. This approval provides an alternative option for patients with dysphagia or who have difficulty swallowing. 
At the end of April, Neurocrine Biosciences, Inc. announced the approval of INGREZZA® SPRINKLE (valbenazine) capsules by the FDA. This approval provides an alternative option for patients with dysphagia or who have difficulty swallowing. 
At the end of April, Neurocrine...
05/15/2024
Psych Congress Network
TD Has ‘Severe Impact’ on Patients and Caregivers
News
TD Has ‘Severe Impact’ on Patients and Caregivers
05/10/2024
Evi Arthur
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was...
05/10/2024
Psych Congress Network
Geriatric Patient with son in long term care setting
News
High Comorbidity, Polypharmacy Burden in Patients With Tardive Dyskinesia in LTC Settings
05/07/2024
Jolynn Tumolo
Patients with tardive dyskinesia (TD) in long-term care settings have a high comorbidity and polypharmacy burden, with half taking medications that may worsen TD, according to a poster presentation at the APA annual meeting.
Patients with tardive dyskinesia (TD) in long-term care settings have a high comorbidity and polypharmacy burden, with half taking medications that may worsen TD, according to a poster presentation at the APA annual meeting.
Patients with tardive dyskinesia...
05/07/2024
Psych Congress Network
Elderly patient and his doctor
News
Awareness of TD Symptoms Linked With Poorer Health, Social Functioning in Patients
05/15/2023
Jolynn Tumolo
Clinician-confirmed possible tardive dyskinesia (TD) was associated with diminished wellness and social functioning in real-world patients, according to a study published online in the Journal of Patient-Reported Outcomes.
Clinician-confirmed possible tardive dyskinesia (TD) was associated with diminished wellness and social functioning in real-world patients, according to a study published online in the Journal of Patient-Reported Outcomes.
Clinician-confirmed possible...
05/15/2023
Psych Congress Network
News
Valbenazine Use for Tardive Dyskinesia in Older Adults Proves Efficacious
12/08/2021
Heather Flint
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive...
12/08/2021
Psych Congress Network
News
Deutetrabenazine is Beneficial for Long-Term Tardive Dyskinesia Treatment
12/03/2021
Meagan Thistle
Deutetrabenazine may provide long-term treatment benefits to patients with tardive dyskinesia (TD), according to a post hoc analysis presented in a poster at Psych Congress 2021.
Deutetrabenazine may provide long-term treatment benefits to patients with tardive dyskinesia (TD), according to a post hoc analysis presented in a poster at Psych Congress 2021.
Deutetrabenazine may provide...
12/03/2021
Psych Congress Network
News
Individual Titration of Deutetrabenazine Beneficial for Patients With Tardive Dyskinesia
11/17/2021
Erin McGuinness
Response-driven titration of deutetrabenazine is beneficial for patients with tardive dyskinesia (TD), according to new findings.
Response-driven titration of deutetrabenazine is beneficial for patients with tardive dyskinesia (TD), according to new findings.
Response-driven titration of...
11/17/2021
Psych Congress Network
spilled bottle of white pills
News
Clozapine Shows Superior Response After First Antipsychotic Failure
03/20/2026
Maria Mantas
Clozapine was more effective than olanzapine and amisulpride in first-episode psychosis (FEP) patients with schizophrenia, schizophreniform, or schizoaffective disorder who did not respond to an initial antipsychotic, according to recent...
Clozapine was more effective than olanzapine and amisulpride in first-episode psychosis (FEP) patients with schizophrenia, schizophreniform, or schizoaffective disorder who did not respond to an initial antipsychotic, according to recent...
Clozapine was more effective...
03/20/2026
Psych Congress Network
a person holds a glass of water and pills
News
Antidepressant Use Patterns May Help Personalize MDD Treatment
03/16/2026
Brionna Mendoza
A new cohort study published in JAMA Psychiatry examined whether real-world antidepressant prescription patterns in MDD patients could help identify biologically meaningful subtypes of depression.
A new cohort study published in JAMA Psychiatry examined whether real-world antidepressant prescription patterns in MDD patients could help identify biologically meaningful subtypes of depression.
A new cohort study published in...
03/16/2026
Psych Congress Network
a man running on a beach
News
Review Urges Greater Exercise Integration in Schizophrenia, SMI Care
03/16/2026
Brionna Mendoza
The integration of physical activity into routine psychiatric care could significantly improve outcomes for people with severe mental illness (SMI), including schizophrenia, according to a narrative review published in JAMA Psychiatry.
The integration of physical activity into routine psychiatric care could significantly improve outcomes for people with severe mental illness (SMI), including schizophrenia, according to a narrative review published in JAMA Psychiatry.
The integration of physical...
03/16/2026
Psych Congress Network
a man sits alone by a lake
News
Loneliness Partially Mediates Link Between Anxiety, Depression, and Suicidal Ideation
03/12/2026
Maria Mantas
Loneliness significantly contributes to the relationship between anxiety symptoms, depressive symptoms, and suicidal ideation among US adults, according to recent analysis findings.
Loneliness significantly contributes to the relationship between anxiety symptoms, depressive symptoms, and suicidal ideation among US adults, according to recent analysis findings.
Loneliness significantly...
03/12/2026
Psych Congress Network
A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
orange pill bottle antidepressant depression major depressive disorder MDD
News
Decision Tool Reduces Antidepressant Dropout in Major Depressive Disorder
03/06/2026
Brionna Mendoza
A clinical decision-support system called PETRUSHKA was found to improve antidepressant continuation in adults with major depressive disorder (MDD). The tool also improved depression and anxiety symptoms.
A clinical decision-support system called PETRUSHKA was found to improve antidepressant continuation in adults with major depressive disorder (MDD). The tool also improved depression and anxiety symptoms.
A clinical decision-support...
03/06/2026
Psych Congress Network
a strand of DNA
News
Copy Number Variant Deletions Linked to Earlier Schizophrenia Onset
03/05/2026
Maria Mantas
Increased copy number variant (CNV) burden, specifically deletions, is associated with earlier age at onset (AAO) of schizophrenia, according to recent research findings.
Increased copy number variant (CNV) burden, specifically deletions, is associated with earlier age at onset (AAO) of schizophrenia, according to recent research findings.
Increased copy number variant...
03/05/2026
Psych Congress Network
an illustration of a man sitting on the ground holding his head with his profile and brain in the background
News
Indirect Costs Drive $366B Schizophrenia Burden in US
02/27/2026
Brionna Mendoza
A comprehensive economic evaluation reported substantial national and state-level societal costs of schizophrenia in the United States for the 2024 calendar year, estimating a total excess societal cost at $366.8 billion.
A comprehensive economic evaluation reported substantial national and state-level societal costs of schizophrenia in the United States for the 2024 calendar year, estimating a total excess societal cost at $366.8 billion.
A comprehensive economic...
02/27/2026
Psych Congress Network
Food and Drug Administration building
News
FDA Approves Milsaperidone for Bipolar I and Schizophrenia in Adults
02/24/2026
Maria Mantas
The FDA has approved milsaperidone for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
The FDA has approved milsaperidone for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
The FDA has approved...
02/24/2026
Psych Congress Network
psilocybin-containing mushrooms in a beaker
News
Synthetic Psilocybin Meets Primary Endpoint in Phase 3 Treatment-Resistant Depression Trial
02/19/2026
Maria Mantas
A synthetic form of psilocybin (COMP360) has met the primary endpoint in a second phase 3 trial evaluating its efficacy and safety in patients with treatment-resistant depression (TRD).
A synthetic form of psilocybin (COMP360) has met the primary endpoint in a second phase 3 trial evaluating its efficacy and safety in patients with treatment-resistant depression (TRD).
A synthetic form of psilocybin...
02/19/2026
Psych Congress Network

Quizzes

amber hoberg, np
Expert Insights Quiz
What screeners should be used to diagnose tardive dyskinesia?
05/26/2023
True or False: According to Nurse Amber Hoberg, the AIMS is the only scale that should be used when screening a patient for tardive dyskinesia (TD).
True or False: According to Nurse Amber Hoberg, the AIMS is the only scale that should be used when screening a patient for tardive dyskinesia (TD).
True or False: According to...
05/26/2023
Psych Congress Network
quiz
Expert Insights Quiz
How does tardive dyskinesia impact medication adherence?
02/14/2023
True or false: Patients with Tardive Dyskinesia (TD) have high rates of antipsychotic medication non-adherence partly due to their TD symptoms.
True or false: Patients with Tardive Dyskinesia (TD) have high rates of antipsychotic medication non-adherence partly due to their TD symptoms.
True or false: Patients with...
02/14/2023
Psych Congress Network
Chepke
Expert Insights Quiz
What is the next step if a patient taking antipsychotics exhibits excessive blink rate?
12/16/2022
As a clinician, if you notice a patient who is taking antipsychotics is exhibiting an excessive blink rate, what should the next step be?
As a clinician, if you notice a patient who is taking antipsychotics is exhibiting an excessive blink rate, what should the next step be?
As a clinician, if you notice a...
12/16/2022
Psych Congress Network
tardive-dyskinesia-quiz
Quiz
The Impact of Tardive Dyskinesia Across Lifestyle Domains
12/10/2021
What percentage of patients with tardive dyskinesia reported their illness having a severe impact across their physical, psychological, and social lives? Take the quiz!
What percentage of patients with tardive dyskinesia reported their illness having a severe impact across their physical, psychological, and social lives? Take the quiz!
What percentage of patients with...
12/10/2021
Psych Congress Network
Quiz
Can long-term anticholinergic medication exposure cause long-term consequences?
10/28/2021
True or false: Long-term anticholinergic medication exposure can cause long-term consequences that surpass previously documented short-term cognitive effects.
True or false: Long-term anticholinergic medication exposure can cause long-term consequences that surpass previously documented short-term cognitive effects.
True or false: Long-term...
10/28/2021
Psych Congress Network
Quiz
Antibody Levels in Schizophrenia Patients With Tardive Dyskinesia
10/15/2021
According to a recent study, what antibody levels were significantly higher in schizophrenia patients with tardive dyskinesia (TD)? Take the quiz to find out!
According to a recent study, what antibody levels were significantly higher in schizophrenia patients with tardive dyskinesia (TD)? Take the quiz to find out!
According to a recent study,...
10/15/2021
Psych Congress Network
Quiz
Quiz: Are These Antibodies Associated with Orofacial Tardive Dyskinesia?
09/09/2021
True or False: A notable percentage of psychiatrists said they would use an anticholinergic medication to manage symptoms of tardive dyskinesia in a patient.
True or False: A notable percentage of psychiatrists said they would use an anticholinergic medication to manage symptoms of tardive dyskinesia in a patient.
True or False: A notable...
09/09/2021
Psych Congress Network
Bottles
Quiz
Updated Treatments for Tardive Dyskinesia
08/16/2021
What are the updated treatments for tardive dyskinesia? Take the quiz and find out!
What are the updated treatments for tardive dyskinesia? Take the quiz and find out!
What are the updated treatments...
08/16/2021
Psych Congress Network
quiz
Quiz
Did psychiatrists say they would use anticholinergic medication for TD treatment?
06/17/2021
True or False: A notable percentage of psychiatrists said they would use an anticholinergic medication to manage symptoms of tardive dyskinesia in a patient.
True or False: A notable percentage of psychiatrists said they would use an anticholinergic medication to manage symptoms of tardive dyskinesia in a patient.
True or False: A notable...
06/17/2021
Psych Congress Network
Quiz
How Often Should Patients Be Evaluated for Tardive Dyskinesia?
05/07/2021
Test your knowledge: How often does the American Psychiatric Association (APA) recommend patients taking either first or second-generation antipsychotics be assessed for tardive dyskinesia?
Test your knowledge: How often does the American Psychiatric Association (APA) recommend patients taking either first or second-generation antipsychotics be assessed for tardive dyskinesia?
Test your knowledge: How often...
05/07/2021
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Pharmacologic Intervention in Bulimia Nervosa
02/26/2026
Maria Mantas
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA guideline recommends? Test your knowledge with this quiz!
Do you remember what the APA...
02/26/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Intranasal Esketamine Dosage for Adult MDD
02/04/2026
Brionna Mendoza
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and administration knowledge with this quiz!
Test your prescribing and...
02/04/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Brain Aging in Schizophrenia
01/22/2026
Maria Mantas
Test your knowledge of recent research with this quick quiz!
Test your knowledge of recent research with this quick quiz!
Test your knowledge of recent...
01/22/2026
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet
Guidelines Quiz
Medication Monitoring in Patients With BPD
01/20/2026
Brionna Mendoza
Test your knowledge of APA guidelines with this quiz!
Test your knowledge of APA guidelines with this quiz!
Test your knowledge of APA...
01/20/2026
Psych Congress Network
Mark Olfson, MD, MPH
Quiz
Telemental Health Use Patterns
01/16/2026
Maria Mantas
Are you caught up with the latest research on telehealth use patterns?
Are you caught up with the latest research on telehealth use patterns?
Are you caught up with the...
01/16/2026
Psych Congress Network
illustration of a laptop screen displaying a test
Quiz
Stimulants and Psychosis Risk in ADHD
12/22/2025
Maria Mantas
Do you remember the findings from this systematic review?
Do you remember the findings from this systematic review?
Do you remember the findings...
12/22/2025
Psych Congress Network
Joseph Goldberg, MD
Quiz
Diagnosing Mixed Features in Bipolar Disorder
12/03/2025
Joseph F. Goldberg, MD
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/03/2025
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Depression, Inflammation, and Insomnia
11/19/2025
Brionna Mendoza
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
11/19/2025
Psych Congress Network
quiz
Quiz
Early Lead Exposure and Mental Health Outcomes
11/10/2025
Maria Mantas
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
11/10/2025
Psych Congress Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use